Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Oncotarget
|
June 10, 2016
MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma
Nathalie Bonnin, Emma Armandy, Julien Carras, et al.
European Urology Focus
|
May 1, 2021
Superselective Ischemia in Robotic Partial Nephrectomy Does Not Provide Better Long-term Renal Function than Renal Artery Clamping in a Randomized Controlled Trial (EMERALD): Should We Take the Risk?
Jean-Alexandre Long, Gaëlle Fiard, Joris Giai, et al.
Molecular Diagnosis & Therapy
|
May 16, 2019
A Multiplex Quantitative Reverse Transcription Polymerase Chain Reaction Assay for the Detection of KIAA1549-BRAF Fusion Transcripts in Formalin-Fixed Paraffin-Embedded Pilocytic Astrocytomas
David Bret, Valentin Chappuis, Delphine Poncet, et al.
Acta Neuropathologica Communications
|
November 11, 2019
The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas
Nathalie Grandin, Bruno Pereira, Camille Cohen, et al.
The Journal of Biological Chemistry
|
March 9, 2004
An anti-apoptotic viral protein that recruits Bax to mitochondria
Delphine Poncet, Nathanael Larochette, Anne-Laure Pauleau, et al.
World Journal of Urology
|
November 11, 2020
The Mayo Adhesive Probability score can help predict intra- and postoperative complications in patients undergoing laparoscopic donor nephrectomy
Quentin Franquet, Xavier Matillon, Nicolas Terrier, et al.
Bulletin Du Cancer
|
July 1, 2014
[Interest of UGT1A1 genotyping within digestive cancers treatment by irinotecan]
Jean-Christophe Boyer, Marie-Christine Etienne-Grimaldi, Fabienne Thomas, et al.
Fundamental & Clinical Pharmacology
|
March 31, 2015
UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice
Marie-Christine Etienne-Grimaldi, Jean-Christophe Boyer, Fabienne Thomas, et al.
Neuro-Oncology Advances
|
May 31, 2021
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults
Thiébaud Picart, Marc Barritault, Delphine Poncet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 25, 2024
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O<sup>6</sup>-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET)
Thomas Walter, Thierry Lecomte, Julien Hadoux, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Oncotarget
|
June 10, 2016
MiR-422a promotes loco-regional recurrence by targeting NT5E/CD73 in head and neck squamous cell carcinoma
Nathalie Bonnin, Emma Armandy, Julien Carras, et al.
European Urology Focus
|
May 1, 2021
Superselective Ischemia in Robotic Partial Nephrectomy Does Not Provide Better Long-term Renal Function than Renal Artery Clamping in a Randomized Controlled Trial (EMERALD): Should We Take the Risk?
Jean-Alexandre Long, Gaëlle Fiard, Joris Giai, et al.
Molecular Diagnosis & Therapy
|
May 16, 2019
A Multiplex Quantitative Reverse Transcription Polymerase Chain Reaction Assay for the Detection of KIAA1549-BRAF Fusion Transcripts in Formalin-Fixed Paraffin-Embedded Pilocytic Astrocytomas
David Bret, Valentin Chappuis, Delphine Poncet, et al.
Acta Neuropathologica Communications
|
November 11, 2019
The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas
Nathalie Grandin, Bruno Pereira, Camille Cohen, et al.
The Journal of Biological Chemistry
|
March 9, 2004
An anti-apoptotic viral protein that recruits Bax to mitochondria
Delphine Poncet, Nathanael Larochette, Anne-Laure Pauleau, et al.
World Journal of Urology
|
November 11, 2020
The Mayo Adhesive Probability score can help predict intra- and postoperative complications in patients undergoing laparoscopic donor nephrectomy
Quentin Franquet, Xavier Matillon, Nicolas Terrier, et al.
Bulletin Du Cancer
|
July 1, 2014
[Interest of UGT1A1 genotyping within digestive cancers treatment by irinotecan]
Jean-Christophe Boyer, Marie-Christine Etienne-Grimaldi, Fabienne Thomas, et al.
Fundamental & Clinical Pharmacology
|
March 31, 2015
UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice
Marie-Christine Etienne-Grimaldi, Jean-Christophe Boyer, Fabienne Thomas, et al.
Neuro-Oncology Advances
|
May 31, 2021
Characteristics of diffuse hemispheric gliomas, H3 G34-mutant in adults
Thiébaud Picart, Marc Barritault, Delphine Poncet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 25, 2024
Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O<sup>6</sup>-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET)
Thomas Walter, Thierry Lecomte, Julien Hadoux, et al.
Page
of 5